Ann: Response to ASX Price Query, page-43

First 43 Last

Share
Profile

Follow
markwhite

790 Posts.

189

05/12/24

17:18

Post #: 76935584
Share

Originally posted by kpax: ↑

Hi all,

When you compare the efficacy data from the Phase 1 SNT-5505 trial on MF and then look at it's combination outcome with Ruxolitinib, a JAK inhibitor, you get a clear hint on what to expect in the next few days .

Have a look SNT quarterly 30/07 to gain an insight of the P1 efficacy data.

Ruxolitinib has 256,233 safety years of data on cumulative patients so roughly ten years patient exposure.

We have the data to explain what it does for patients. Very soon we will have a combination drug for a 1 billion per year turnover.

No wonder SNT are nervous. The data has been coming in since approximately May this year. Still needs a peer review before the conference. Why because the data is so good.

Have a look at Hashan De Silva on LinkedIn. His last post and his third last post. (Non Executive Director SNT)

I am content on this play.

Cant wait to get the interim results to do my own peer review and post same .

Kpax

Expand

@kpax can you please post here what Hashan said?

SNT Price at posting: 6.4¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NMT

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 43 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 5.0¢		Change -0.003(5.66%)		Mkt cap ! $81.24M

Open	High	Low	Value	Volume
5.2¢	5.3¢	4.9¢	$146.4K	2.891M

Buyers (Bids)

No.	Vol.	Price($)
5	476329	4.9¢

Sellers (Offers)

Price($)	Vol.	No.
5.1¢	558010	7

View Market Depth

No.	Vol.	Price($)
5	476329	0.049
3	241000	0.048
2	210276	0.047
3	950000	0.046
9	1504898	0.045

Price($)	Vol.	No.
0.051	558010	7
0.052	497290	4
0.053	369974	1
0.054	498849	2
0.055	203600	2

Last trade - 12.30pm 26/06/2025 (20 minute delay)

SNT (ASX) Chart

Ann: Response to ASX Price Query, page-43

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Australia’s gas crisis is here – and dying coal plants aren’t helping

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Response to ASX Price Query, page-43

Top Stories

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Australia’s gas crisis is here – and dying coal plants aren’t helping

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News